Archives for March 4, 2008

← 2008

Asia glitters gold for pharma

By  Kirsty Barnes

Asia has been dubbed the "land of golden opportunities" by PricewaterhouseCoopers (PWC), who says it is poised to become the largest pharmaceutical consumer and producer in the world.

Applera shake up as company does the splits

By  Wai Lang Chu

Applera has announced its intentions to separate its Celera Group from the Applera Corporation, forming a separate, publicly-traded company, subject to approval from the US Securities and Exchange Commission and Applera's board of directors.

ACT licence beefs up Pharmings transgenic cattle portfolio

By  Pete Mansell

Dutch biotech Pharming has solidified its patent position in the use of transgenic cattle to produce protein therapeutics through a licence agreement with Advanced Cell Technology (ACT), a US company developing stem cell therapies for regenerative...

DiaMed helps Bio-Rad to strong growth in 07

By  David Robson

Bio-Rad Laboratories has reported strong growth in the last quarter of 2007, with a 34 per cent increase in revenue compared to the last quarter of 2006. These results have contributed to an overall 14.7 per cent increase in sales for 2007, to $1.46bn.

Supply chain globalisation weighs heavily on FDA

By  Pete Mansell

The globalisation of the supply chain increasingly challenges the US Food and Drug Administration's ability to ensure the quality of pharmaceuticals on the US market, acknowledges the acting director of the agency's Center for Drug Evaluation and...